Thermo Fisher Scientific Inc. (0R0H.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
With a PE ratio of 24.59 and EPS of 19.19, Thermo Fisher Scientific is priced at a reasonable premium consistent with a high‑quality, large‑cap life sciences company. The valuation suggests investors still expect solid earnings durability, but the multiple is not excessively stretched relative to historical levels for a defensive, high‑margin business. Without detailed recent revenue and margin data, the earnings profile looks stable rather than clearly accelerating, pointing to a neutral overall read on fundamentals.
The stock trades at $471.75, about 9–10% below its 200‑day moving average of $522.32, indicating it is in a medium‑term downtrend despite a 4.3% gain over the last month. An RSI of 47.45 is neutral, suggesting neither overbought nor oversold conditions and no strong momentum signal. Overall, the technical picture leans bearish to mildly negative until the price can sustain a move back above the 200‑day moving average.
Alternative data for Thermo Fisher Scientific is broadly constructive: web traffic is substantial, hiring is robust with job openings up 33.3% month over month, and social media followings are steadily growing across most major platforms. The hiring surge in particular typically signals confidence in future demand and ongoing investment in capacity and innovation. Social presence trends, especially on LinkedIn, support the view of a strong brand and continued engagement with customers and talent.
Thermo Fisher Scientific’s fundamentals and valuation appear solid and consistent with a high‑quality, profitable company, but the stock remains in a technical downtrend below its 200‑day moving average. At the same time, alternative data—particularly strong hiring and growing digital and social engagement—points to management confidence and underlying business strength. Balancing the constructive operational and alternative data signals against the still‑weak technical setup leads to an overall neutral stance on the stock in the near term.
You don't hold 0R0H.L in your mock portfolio yet.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started